Chris Takimoto
Chief Tech/Sci/R&D Officer presso IGM BIOSCIENCES, INC.
Patrimonio netto: 910 844 $ in data 31/03/2024
Profilo
Chris H.
Takimoto is currently the Chief Medical Officer at IGM Biosciences, Inc. He previously held senior positions at Gilead Sciences, Inc., Forty Seven, Inc., Ortho Biotech Oncology Research & Development, and Janssen Global Services LLC.
He also worked as an Associate Professor at the University of Texas Health Science Center at San Antonio.
Takimoto received his undergraduate degree from Stanford University and his doctorate from Yale University and the Yale School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0.28% | 14/03/2024 | 94 388 ( 0.28% ) | 910 844 $ | 31/03/2024 |
Posizioni attive di Chris Takimoto
| Società | Posizione | Inizio |
|---|---|---|
| IGM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29/07/2021 |
Precedenti posizioni note di Chris Takimoto
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2021 |
| FORTY SEVEN, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01/01/2016 |
| Ortho Biotech Oncology Research & Development | Corporate Officer/Principal | 01/01/2010 |
| University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | - |
Formazione di Chris Takimoto
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
| Yale School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
| Ortho Biotech Oncology Research & Development | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Borsa valori
- Insiders
- Chris Takimoto
